The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

Publication

Complement activation induces excessive T cell cytotoxicity in severe COVID-19


Authors:

  • Georg, Philipp
  • Astaburuaga-García, Rosario
  • Bonaguro, Lorenzo
  • Brumhard, Sophia
  • Michalick, Laura
  • Lippert, Lena J.
  • Kostevc, Tomislav
  • Gäbel, Christiane
  • Schneider, Maria
  • Streitz, Mathias
  • Demichev, Vadim
  • Gemünd, Ioanna
  • Barone, Matthias
  • Tober-Lau, Pinkus
  • Helbig, Elisa T.
  • Hillus, David
  • Petrov, Lev
  • Stein, Julia
  • Dey, Hannah-Philine
  • Paclik, Daniela
  • Iwert, Christina
  • Mülleder, Michael
  • Aulakh, Simran Kaur
  • Djudjaj, Sonja
  • Bülow, Roman D.
  • Mei, Henrik E.
  • Schulz, Axel R.
  • Thiel, Andreas
  • Hippenstiel, Stefan
  • Saliba, Antoine-Emmanuel
  • Eils, Roland
  • Lehmann, Irina
  • Mall, Marcus A.
  • Stricker, Sebastian
  • Röhmel, Jobst
  • Corman, Victor M.
  • Beule, Dieter
  • Wyler, Emanuel
  • Landthaler, Markus
  • Obermayer, Benedikt
  • von Stillfried, Saskia
  • Boor, Peter
  • Demir, Münevver
  • Wesselmann, Hans
  • Suttorp, Norbert
  • Uhrig, Alexander
  • Müller-Redetzky, Holger
  • Nattermann, Jacob
  • Kuebler, Wolfgang M.
  • Meisel, Christian
  • Ralser, Markus
  • Schultze, Joachim L.
  • Aschenbrenner, Anna C.
  • Thibeault, Charlotte
  • Kurth, Florian
  • Sander, Leif E.
  • Blüthgen, Nils
  • Sawitzki, Birgit

Details:

Cell, Volume 185, Issue 3, 2022-02-03

Article Link: Click here

Severe COVID-19 is linked to both dysfunctional immune response and unrestrained immunopathology, and it remains unclear whether T cells contribute to disease pathology. Here, we combined single-cell transcriptomics and single-cell proteomics with mechanistic studies to assess pathogenic T cell functions and inducing signals. We identified highly activated CD16+ T cells with increased cytotoxic functions in severe COVID-19. CD16 expression enabled immune-complex-mediated, T cell receptor-independent degranulation and cytotoxicity not found in other diseases. CD16+ T cells from COVID-19 patients promoted microvascular endothelial cell injury and release of neutrophil and monocyte chemoattractants. CD16+ T cell clones persisted beyond acute disease maintaining their cytotoxic phenotype. Increased generation of C3a in severe COVID-19 induced activated CD16+ cytotoxic T cells. Proportions of activated CD16+ T cells and plasma levels of complement proteins upstream of C3a were associated with fatal outcome of COVID-19, supporting a pathological role of exacerbated cytotoxicity and complement activation in COVID-19.